Table: Oncolys Biopharma -2020 parent results
Feb 12 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2020 Dec 31, 2019 Dec 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 314 mln 1.30
(-75.9 pct) (+673.5 pct)
Operating loss 1.67 loss 511 mln
Recurring loss 1.72 loss 539 mln
Net loss 2.10 loss 912 mln
EPS loss 145.58 yen loss 65.55 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T